🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsSmall molecule vs peptide GLP-1 agonists — binding affinity comparison Page 2

Small molecule vs peptide GLP-1 agonists — binding affinity comparison

PeptideChemSF Sun, May 31, 2026 at 5:43 PM 16 replies 583 viewsPage 2 of 4
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
May 31, 2026 at 7:16 PM#6

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

That is the short version; the long version is somebody else's post.

44 14LindaRN_retired, tommy_boulder, hyun_seoul and 41 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
May 31, 2026 at 7:52 PM#7

A narrower follow-up, since the general answer is now clear:

Whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong?

Last edited: May 31, 2026 at 11:52 PM
43 13raj_cambridge, ingrid_STO, pete_nash and 40 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
May 31, 2026 at 8:28 PM#8
BiostatsBrad said:
If you are going to change something, change one thing and give it long enough to express itself.

Coming at BiostatsBrad’s question from a different direction. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Jun 1, 2026 at 12:28 AM
42 12TomTeleRx, DoseLogDan, SleepFixSam and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 31, 2026 at 9:04 PM#9

Closing the loop on my own question.

I moved the tablet to the moment I wake up rather than trying to fit it around breakfast, and the difference in the following weeks was obvious. It was a timing problem, not a dose problem.

41 11ricardo_MIA, BrianDallas92, labquiet_amy and 38 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
May 31, 2026 at 11:59 PM#10
TrialNerd_Beth said:
The useful move here is to separate what is established from what is widely repeated.

TrialNerd_Beth has the substance of this right. The condition it depends on is worth stating. The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest. Where it bites is in the first fortnight, when people conclude the tablet does nothing.

Last edited: Jun 1, 2026 at 2:59 AM
3 1SandraNC_45, Dr.EndoIndy, tom_AK
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register